Green Cross Medical Science Corporation (KOSDAQ:142280)
4,025.00
-15.00 (-0.37%)
At close: Aug 6, 2025, 3:30 PM KST
Paramount Global Revenue
Green Cross Medical Science had revenue of 26.48B KRW in the quarter ending March 31, 2025, with 11.75% growth. This brings the company's revenue in the last twelve months to 106.64B, up 13.07% year-over-year. In the year 2024, Green Cross Medical Science had annual revenue of 103.85B with 10.47% growth.
Revenue (ttm)
106.64B
Revenue Growth
+13.07%
P/S Ratio
0.84
Revenue / Employee
874.06M
Employees
122
Market Cap
89.43B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 103.85B | 9.84B | 10.47% |
Dec 31, 2023 | 94.01B | -19.10B | -16.88% |
Dec 31, 2022 | 113.11B | 11.43B | 11.25% |
Dec 31, 2021 | 101.67B | -11.70B | -10.32% |
Dec 31, 2020 | 113.38B | 31.88B | 39.13% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 308.59T |
SK hynix | 77.21T |
LG Energy Solution | 25.76T |
Samsung Biologics | 4,898.69B |
Hanwha Aerospace | 15.28T |
Hyundai Motor Company | 178.98T |
HD Hyundai Heavy Industries | 15.32T |
Doosan Enerbility | 15.88T |